TL-201 SCANNING FOR THE EVALUATION OF OSTEOSARCOMA AND SOFT-TISSUE SARCOMA - A STUDY OF THE EVALUATION AND PREDICTABILITY OF THE HISTOLOGICAL RESPONSE TO CHEMOTHERAPY

Citation
Lr. Menendez et al., TL-201 SCANNING FOR THE EVALUATION OF OSTEOSARCOMA AND SOFT-TISSUE SARCOMA - A STUDY OF THE EVALUATION AND PREDICTABILITY OF THE HISTOLOGICAL RESPONSE TO CHEMOTHERAPY, Journal of bone and joint surgery. American volume, 75A(4), 1993, pp. 526-531
Citations number
23
Categorie Soggetti
Orthopedics,Surgery
ISSN journal
00219355
Volume
75A
Issue
4
Year of publication
1993
Pages
526 - 531
Database
ISI
SICI code
0021-9355(1993)75A:4<526:TSFTEO>2.0.ZU;2-X
Abstract
We evaluated sequential thallium scans, made before and after a period of preoperative chemotherapy, for sixteen patients who had a high-gra de sarcoma of bone or soft tissue. The purpose was to determine whethe r this technique could be used to ascertain accurately the amount of v iable tumor as well as to predict the response to chemotherapy. Nine o f the ten patients who had a reduced thallium uptake after chemotherap y also had a marked histological response, with necrosis of the tumor of at least 95 per cent. Six patients were seen to have no improvement on the thallium scans, and this finding correlated with necrosis of t he tumor of less than 95 per cent. Thallium chloride has been shown to have an affinity for a variety of osteosarcomas and soft-tissue sarco mas. The mechanism of intracellular uptake is one of active transport, which makes thallium chloride a more accurate barometer of the viabil ity of the tumor cells and of metabolic activity than scanning agents that are flow-dependent. We believe that sequential thallium scintigra phy should be used in conjunction with other imaging modalities in the diagnosis, planning of treatment, and follow-up evaluation of patient s who have a sarcoma of bone or soft tissue. This technique appears to be useful in the prediction of the histological response of high-grad e osteosarcomas and soft-tissue sarcomas to preoperative chemotherapy.